1. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study 
Dr Danielle V Clark, PhD, Hannah Kibuuka, MD, Monica Millard, MPH, Salim Wakabi, MD, Luswa Lukwago, MPH, Alison Taylor, BS, Michael A Eller, PhD, Leigh Anne Eller, PhD, Nelson L Michael, MD, Anna N Honko, PhD, Gene G Olinger, PhD, Randal J Schoepp, PhD, Matthew J Hepburn, MD, Lisa E Hensley, PhD, Merlin L Robb, MD 
The Lancet Infectious Diseases 
Volume 15, Issue 8, Pages (August 2015)
DOI: /S (15)
Copyright © 2015 Elsevier Ltd Terms and Conditions

2. Figure
Study profile
Two contacts of suspected Bundibugyo Ebola virus (BDBV) cases had antibodies against filovirus species, for 15 seropositive contacts. We were unable to locate ten survivors, and two survivors had moved to a different district. One survivor refused to participate. Survivors younger than 18 years or those who did not meet the suspect case definition were ineligible for the study.
The Lancet Infectious Diseases  , DOI: ( /S (15) )
Copyright © 2015 Elsevier Ltd Terms and Conditions